Søren Møller Nielsen

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

Thomas Ruhland, K. G. Jensen, Morten Jørgensen, 2011, Journal of medicinal chemistry.

The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.

S. Poda, F. Loechel, C. Volbracht, 2014, Bioorganic & medicinal chemistry letters.